Home »
Vulvar Cancer Global Clinical Trials Review, H1, 2012

Vulvar Cancer Global Clinical Trials Review, H1, 2012

Double click on above image to view full picture

Email to a Colleague - Print - Fax Order

Additional Information

Price	$1,000.00
Publisher	GlobalData
Date of Report	Jan 27, 2012

Add to Wishlist | Add to Compare

Qty:

-OR-

Quick Overview

Vulvar Cancer Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H1, 2012" provides data on the Vulvar Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vulvar Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vulvar Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vulvar Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Nations 12
Clinical Trials in G7 Nations by Trial Status 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Unaccomplished Trials of Vulvar Cancer 17
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Top Companies Participating in Vulvar Cancer Therapeutics Clinical Trials 22
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Merck & Co., Inc. 24
Clinical Trial Overview of Merck & Co., Inc. 24
UMC Utrecht 25
Clinical Trial Overview of UMC Utrecht 25
Precision Therapeutics, Inc. 26
Clinical Trial Overview of Precision Therapeutics, Inc. 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 27
Gynecologic Oncology Group 27
Clinical Trial Overview of Gynecologic Oncology Group 27
The University of Texas M. D. Anderson Cancer Center 28
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 28
Leiden University Medical Center 29
Clinical Trial Overview of Leiden University Medical Center 29
Case Comprehensive Cancer Center 30
Clinical Trial Overview of Case Comprehensive Cancer Center 30
Northwestern University 31
Clinical Trial Overview of Northwestern University 31
Memorial Sloan Kettering Cancer Center 32
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 32
European Organization for Research and Treatment of Cancer 33
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 33
University Medical Center Groningen 34
Clinical Trial Overview of University Medical Center Groningen 34
Masonic Cancer Center 35
Clinical Trial Overview of Masonic Cancer Center 35
Brigham and Women's Hospital 36
Clinical Trial Overview of Brigham and Women's Hospital 36
The Christie NHS Foundation Trust 37
Clinical Trial Overview of The Christie NHS Foundation Trust 37
Centre Oscar Lambret 38
Clinical Trial Overview of Centre Oscar Lambret 38
Abramson Cancer Center 39
Clinical Trial Overview of Abramson Cancer Center 39
Erasmus MC 40
Clinical Trial Overview of Erasmus MC 40
Cardiff University 41
Clinical Trial Overview of Cardiff University 41
Burzynski Research Institute, Inc. 42
Clinical Trial Overview of Burzynski Research Institute, Inc. 42
University of Toronto 43
Clinical Trial Overview of University of Toronto 43
Women and Infants Hospital of Rhode Island 44
Clinical Trial Overview of Women and Infants Hospital of Rhode Island 44
Dana-Farber Cancer Institute 45
Clinical Trial Overview of Dana-Farber Cancer Institute 45
Roswell Park Cancer Institute 46
Clinical Trial Overview of Roswell Park Cancer Institute 46
Five Key Clinical Profiles 47
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 10
Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 11
Vulvar Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 12
Vulvar Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 14
Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 15
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16
Vulvar Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 17
Vulvar Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 18
Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 21
Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 22
Vulvar Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 23
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 24
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012* 25
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Precision Therapeutics, Inc., 2012* 26
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2012* 27
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 28
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2012* 29
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 30
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 31
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 32
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 33
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2012* 34
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012* 35
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012* 36
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Christie NHS Foundation Trust, 2012* 37
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Oscar Lambret, 2012* 38
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012* 39
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012* 40
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2012* 41
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2012* 42
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2012* 43
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Women and Infants Hospital of Rhode Island, 2012* 44
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 45
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 46

List of Figures
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 10
Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 11
Vulvar Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 12
Vulvar Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 14
Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 15
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16
Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 20
Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 22
Vulvar Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 23
GlobalData Methodology 76